SCHEMBL30897136

SCHEMBL30897136

N#Cc1cccc(Br)c1OCCC(CN)N=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761182 0.71 TSHR (0.39) —
SCHEMBL25816117 0.71 PTGES (0.35) —
SCHEMBL28053434 0.70 AR (0.37) —
SCHEMBL29122661 0.69 DYRK1A (0.38) —
SCHEMBL30897137 0.69 DYRK1A (0.32) —
SCHEMBL24553670 0.69 DYRK1A (0.35) —
SCHEMBL1761232 0.69 MAOB (0.50) —
SCHEMBL28312806 0.66 THRA (0.40) —
SCHEMBL27990728 0.66 MAP3K7 (0.40) —
SCHEMBL21143326 0.64 EGFR (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608808-A1 SOMATOSTATIN RECEPTOR 2 AGONISTS AND USES THEREOF Basecamp Bio Inc. (KY) 2025-09-03 — — EP disclosed
Send feedback